Picture of Jaguar Health logo

JAGX — Jaguar Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Jaguar Health Inc expected to post a loss of 7 cents a share - Earnings Preview

* Jaguar Health Inc  JAGX.OQ   JAGX.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 14. 
    * The San Francisco California-based  company is expected to
report  a 463.5% increase in revenue to $3.55 million from $630
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Jaguar Health Inc
is for
a loss of 7 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Jaguar
Health Inc
is $4​, above​ its last closing price of $0.13. ​​​

This summary was machine generated November 11 at 17:53 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Jaguar Health

See all news